Medical News

RSS

Sunshine Biopharma to present new Adva-27a data against cancer at AACR meeting

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that they will be presenting scientific data at the American Association for Cancer Research Meeting April 2-6, 2011 in Orlando Florida.

2 Apr 2011

APA to host 2011 Psychologically Healthy Workplace Conference in Chicago

The American Psychological Association's 2011 Psychologically Healthy Workplace Conference will be held April 8-9 in Chicago.

2 Apr 2011

The Economist examines factors contributing to antimicrobial resistance

"Antibiotic resistance has now become a costly and dangerous problem," The Economist writes in an article examining the factors that have contributed to the global rise of antibiotic resistant bacteria, ahead of next week's World Health Day dedicated to the issue.

2 Apr 2011

Idera's IMO-2125 plus ribavirin Phase 1 trial results against HCV presented at EASL meeting

Idera Pharmaceuticals, Inc. announced today the presentation of data from a four-week Phase 1 clinical trial of IMO-2125 in combination with ribavirin in treatment-naïve patients chronically infected with hepatitis C virus genotype 1.

2 Apr 2011

MSD's Victrelis Phase III trial final results against HCV presented at EASL meeting

MSD reported that final results from a Phase III study of 'Victrelis', its investigational oral hepatitis C protease inhibitor, added to peginterferon alfa-2a marketed by Roche Products Limited, and ribavirin therapy were presented for the first time today as part of a late-breaker poster session at The International Liver Congress / 46th European Association for the Study of the Liver annual meeting.

2 Apr 2011

CCEI offers course on child abuse in honor of National Child Abuse Prevention Month

ChildCare Education Institute, a nationally accredited, IACET CEU granting, distance training institution dedicated exclusively to the child care industry, offers new users the opportunity to try online learning by taking the course CCEI112A: Child Abuse: Signs of Abuse and Reporting Requirements for Early Childhood Professionals at no cost for the month of April, in honor of National Child Abuse Prevention Month.

2 Apr 2011

Array BioPharma to unveil new findings about its anti-cancer programs at AACR Annual Meeting

Array BioPharma Inc. today announced that five abstracts have been selected for presentation at the American Association for Cancer Research Annual Meeting, being held from April 2-6, 2010, at the Orange County Convention Center in Orlando, Fla.

2 Apr 2011

Boehringer Ingelheim's BI 201335 new data against HCV highlighted at EASL meeting

New data presented today at the International Liver CongressTM 2011, the 46th Annual Meeting of the European Association for the Study of the Liver, in Berlin, highlighted the efficacy of Boehringer Ingelheim's once-daily oral protease inhibitor BI 201335, in both treatment-naïve and -experienced patients with chronic genotype-1 hepatitis C virus infection. Genotype-1 HCV is the most challenging genotype of HCV to treat.

2 Apr 2011

Transgenomic to present study results of high-sensitivity cancer mutation assays at AACR

Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.

2 Apr 2011

Funds at risk: What services does Title X support?

In places like Unity Health Care's Upper Cardozo clinic in the Columbia Heights neighborhood of Washington, D.C., doctors, nurses and other health care providers are too busy treating patients to focus on the fights happening across town.

2 Apr 2011

Thalidomide provides new hope for patients with difficult to treat liver cancer

Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma, according to data presented at the International Liver Congress 2011.

2 Apr 2011

Prevalence of NAFLD in US expected to increase by 50% in 2030: Study

According to new data presented today at the International Liver CongressTM, the United States could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease, one of the major contributing factors of chronic liver disease, considered as one of the major causes of morbidity and mortality worldwide.

2 Apr 2011

Boehringer Ingelheim advances into Phase 3 clinical trial of BI 201335

Boehringer Ingelheim today announced a preview of the study designs for the pivotal Phase 3 clinical trials evaluating BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naive and -experienced patients with chronic genotype-1 hepatitis C virus, the most challenging genotype to treat.

2 Apr 2011

CAS-Carrera awarded $3.5M SIF grant from EMCF

The New York based Children's Aid Society Carrera Adolescent Pregnancy Prevention Program has been awarded a $3.5 million Social Innovation Fund grant from the Edna McConnell Clark Foundation to deepen the program's impact in New York City and replicate it nationally.

2 Apr 2011

Report shows a continued decline in diagnoses, deaths for many types of cancers

Once again, the Annual Report to the Nation on the Status of Cancer shows a continued decline in diagnoses and deaths for many types of cancers. This encouraging news can be attributed primarily to preventive measures such as cessation of smoking and improved diet, and early detection.

2 Apr 2011

Series of new clinical trials confirm range of viable treatment options for HCV patients

Highly anticipated data from a number of clinical trials presented for the first time at the International Liver CongressTM confirmed that a range of new proteases inhibitors will help treat patients who have previously failed therapy for the treatment of chronic hepatitis C.

2 Apr 2011

VSP launches mobile version for members to access vision care information

VSP Vision Care today launched the mobile version of vsp.com that allows members to access their vision care information from anywhere. Using a smartphone device, VSP members have access to features including: find a doctor, check your benefits, access your vision card and browse the eyewear gallery.

2 Apr 2011

New research identifies diverse barriers to breast cancer screening and treatment

A landmark breast health care publication reveals a multitude of barriers that keep women of developing nations from being screened and treated for breast cancer - but offers tools to help countries improve their breast care programs.

2 Apr 2011

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of three abstracts from the SuperGen PIM kinase inhibitor program. Poster presentations by SuperGen and collaborators will occur on April 3 and 5, 2011 at the American Association for Cancer Research 102nd Annual Meeting in Orlando, Florida.

2 Apr 2011

Skilled Healthcare Group's RCO signs operating lease for Lindenwood Nursing Home in Omaha

Skilled Healthcare Group, Inc. today announced that its wholly owned company, The Rehabilitation Center of Omaha, LLC has signed an operating lease for 10 years for Lindenwood Nursing Home in Omaha, Nebraska with two additional five-year extensions. The lease also provides RCO with a purchase option and the landlord with a sale option, beginning in year six of the lease.

2 Apr 2011

Medical News

Sunshine Biopharma to present new Adva-27a data against cancer at AACR meeting

APA to host 2011 Psychologically Healthy Workplace Conference in Chicago

The Economist examines factors contributing to antimicrobial resistance

Idera's IMO-2125 plus ribavirin Phase 1 trial results against HCV presented at EASL meeting

MSD's Victrelis Phase III trial final results against HCV presented at EASL meeting

CCEI offers course on child abuse in honor of National Child Abuse Prevention Month

Array BioPharma to unveil new findings about its anti-cancer programs at AACR Annual Meeting

Boehringer Ingelheim's BI 201335 new data against HCV highlighted at EASL meeting

Transgenomic to present study results of high-sensitivity cancer mutation assays at AACR

Funds at risk: What services does Title X support?

Thalidomide provides new hope for patients with difficult to treat liver cancer

Prevalence of NAFLD in US expected to increase by 50% in 2030: Study

Boehringer Ingelheim advances into Phase 3 clinical trial of BI 201335

CAS-Carrera awarded $3.5M SIF grant from EMCF

Report shows a continued decline in diagnoses, deaths for many types of cancers

Series of new clinical trials confirm range of viable treatment options for HCV patients

VSP launches mobile version for members to access vision care information

New research identifies diverse barriers to breast cancer screening and treatment

Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR

Skilled Healthcare Group's RCO signs operating lease for Lindenwood Nursing Home in Omaha

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News